In large obesity trials using full doses, once-weekly semaglutide and tirzepatide led to substantial average weight loss and improved metabolic markers in adults with obesity.[13] For example, the STEP 1 trial of once-weekly semaglutide in adults with overweight or obesity and the SURMOUNT-1 tirzepatide obesity trial both showed strong weight-loss effects when combined with lifestyle changes
This guide compares semaglutide and tirzepatide, including timelines, dosing charts, expected results, side effects, and factors providers consider when helping patients choose between these treatments
By analyzing dispensing data, this study examined trends in the first-time dispensing of semaglutide and tirzepatide among adults with CVD and overweight or obesity
Glutathione can contribute to a lighter skin tone when used consistently and over time by inhibiting the production of melanin, the pigment responsible for skin color
Here's a plain-English summary of what the FDA timeline means for compounded GLP-1 programs like Sunlight